New HIV pill for kids under study
NCT ID NCT06139796
First seen Oct 31, 2025 · Last updated May 08, 2026 · Updated 22 times
Summary
This study was designed to test a new, easier-to-take HIV medicine for children aged 3 years and older who weigh between 10 and 25 kg. The goal was to find the right dose and check if the drug is safe and acceptable for kids. However, the study was withdrawn before any participants were enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor College of Medicine Children's Foundation
Kampala, Uganda, 72052, Uganda
-
Centre Hospitalier National d'Enfants Albert Royer
Dakar, Senegal, 25755, Senegal
-
Centre Mère et Enfant de la Fondation Chantal Biya
Yaoundé, Cameroon, 1, Cameroon
-
Joint Clinical Research Centre (JCRC)
Kampala, Uganda
-
University of Zimbabwe Clinical Research Centre (UZCRC)
Harare, Zimbabwe, Zimbabwe
Conditions
Explore the condition pages connected to this study.